Search

everythinglearnresearchcommunity

for

Search:↓

Unapproved stem cell therapies are marketed online in the UK, raising safety and regulation concerns.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

Trichoscopy helps diagnose hair and scalp problems but isn't always definitive and should be used with other methods.

New treatments for skin and hair repair show promise, but further improvements are needed.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

PRP, exosomes, and physical therapies show promise for hair and tissue repair, but need more research for optimization.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Fat-derived stem cells, platelet-rich plasma, and biomaterials show promise for healing chronic skin wounds and improving soft tissue with few side effects.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Understanding EGFR roles could lead to new hair loss treatments.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.